Black Diamond Therapeutics, Inc. - Common Stock — 재무제표 (NASDAQ:BDTX) | MetaTrader

전체 차트 열기 Full chart

뉴스

BDTX Broadens EGFR Reach into Glioblastoma, Adding a Fresh Catalyst

Black Diamond Stock Outlook After Q1 Beat and Cash Runway

BDTX Silevertinib Data in EGFR NSCLC: What Investors Need to Know

What's Going On With Black Diamond Therapeutics Stock Tuesday? - Black Diamond Therapeutic (NASDAQ:BDTX)

BDTX Stock Slumps on Mixed Phase II Frontline NSCLC Study Data

BDTX Shares Gain 11% in a Week: Here's What You Should Know

Implied Volatility Surging for Black Diamond Therapeutics Stock Options

BDTX and the CNS-Active EGFR Trend: Why C797S Is the Prize

BDTX Stock: Neutral Zacks Rank, $4 Target, and What Must Go Right

Black Diamond's Lead Drug Silevertinib: Key Data, Catalysts, and Risks

Why Is Black Diamond (BDTX) Up 19.3% Since Last Earnings Report?

BDTX and Brain Metastases: Why CNS Activity Could Matter in 2026